Drug General Information
Drug ID D0L4JT
Drug Name Sulfanilamide
Synonyms AAS; AVC; Albexan; Albosal; Ambeside; Antistrept; Astreptine; Astrocid; Bactesid; Collomide; Colsulanyde; Copticide; Deseptyl; Desseptyl; Dipron; Ergaseptine; Gerison; Gombardol; Infepan; Lusil; Lysococcine; Neococcyl; Orgaseptine; PABS; Prontalbin; Prontylin; Proseptal; Proseptine; Pysococcine; SAN; Sanamid; Septanilam; Septolix; Septoplex; Septoplix; Solfanilamide; Stramid; Strepamide; Streptagol; Streptamid; Streptocid; Streptocide; Streptocidum; Streptocom; Streptol; Strepton; Streptopan; Streptrocide; Sulfanilamida; Sulfanilamidum; Sulfocidin; Therapol; Tolder; Prontosil I; Prontosil White; Pronzin Album; Rubiazol A; Septamide Album; Solfanilamide [DCIT]; Stopton Album; Streptocid album; Streptocide White; Sulfanilamide Vaginal Cream; Sulphanilamide Extra Pure; Sulphanilamide Gr; White streptocide; F 1162; Fourneau 1162; Ro13354; A-349; AVC (TN); Aromatic/heteroaromatic sulfonamide 2; F-1162; P-Aminobenzenesulfonylamide; P-Aminobenzensulfonamide; Streptocid (TN); Streptocide (VAN); Sulfanilamida [INN-Spanish]; Sulfanilamide (INN); Sulfanilamide [INN:DCF]; Sulfanilamidum [INN-Latin]; Aniline-p-sulfonic amide; I.C. 56; BENZENESULFONIC ACID,4-AMINO,AMIDE SULFANILAMIDE; N4,N4-Bis(2-bromoethyl)sulfanilamide; N(sup 4),N(sup 4)-Bis(2-bromoethyl)sulfanilamide; N(sup4),N(sup4)-Bis(2-bromoethyl)sulfanilamide; Benzenesulfonamide, 4-(bis(2-bromoethyl)amino)-(9CI); Sulfanilamide, N4,N4-bis(2-bromoethyl)-(8CI); 1162 F; 4-(Bis(2-bromoethyl)amino)benzenesulfonamide; 4-Aminobenzene-1-Sulfonamide; 4-Aminophenylsulfonamide; 4-Sulfamoylaniline; 4-[bis(2-bromoethyl)amino]benzenesulfonamide
Drug Type Small molecular drug
Therapeutic Class Antibiotics
Structure D0L4JT
Drug Resistance Mutations
Target Name Fungal Folic acid synthesis protein (fol1) Target Info
Gene Name FOL1
Uniprot ID L0P7Z1_PNEJ8
Species Pneumocystis jiroveci
Reference Sequence MRFKSINLKIVPFYQICYFKSVTRIFFGRDIHSLKLNKDYDLIHIHSLTLKSIIGKNLWA
QKLLQPVFLTLSFRKNTTFLENLDDLSYSIDYTIVYKEVYKLVESSEFQDLADLADKISE
LVFSHKCKANWVKIKIETPKGNLFAGTGLQVVRRKDGIVEVDDQFFVKKLSLFTIIGMNP
EEMINKQNIIINLILYKSPINLEDRNCSIINIYNIEKVLKEIVKHVESSSFKTIEALALS
IARILCISHNIEKIKVNVEKPSALAFARSAGVEIVRSRSCFFSDDYINSKGPVDNDAIYI
ALGSNLGNKVKFISDAIEKMSIRGIKVLKTSMLYESEPMYFKDQPVFYNAVCKVETSLNP
KQLLDELKTIEKEFGRVKTIDKGPRCIDLDIIFFRRKIINSESLIVPHPQALERPFVLKP
LCDISNDLVHPITGLPIVSYLKKIVNPGIKPVLPFLYKNRSINFSSEFYKAPTHIMAILN
LTPDSFFDGGVHSYDSILMDVENFINAGATIIDIGGQSTRSGSHVVSIEEEISRVIPAIK
YLLKVYPDILVSVDTFRSEVAEQAIKAGASLVNDISGGRYDPKMLNVVAKLKVPICIMHM
RGDFLTMDNLTDYGTDIIKQITKELEELLVFAESSGIFRWNIILDPGLGFAKTSYQNIEL
LRRFNELKSQHCFNGLPWLLGPSRKRFTGCLTGDVMPKDRIWGTAASVAASVLGGCDIIR
VHDVYEMYKVSRTLDAIWKGVY [Pneumocystis jiroveci]
Targeted Disease Pneumocystis infection
Drug Resistance Mutations
Mutation info Missense: W55A [1]
References
REF 1 Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 2004 Jul;48(7):2610-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.